Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dapagliflozin/gemigliptin/metformin - LG Chem

Next Previous
Drug Profile

Dapagliflozin/gemigliptin/metformin - LG Chem

Alternative Names: gemigliptin/dapagliflozin/metformin 50/10/1000 mg

Latest Information Update: 03 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LG Chem
  • Class 2 ring heterocyclic compounds; Amines; Benzhydryl compounds; Biguanides; Chlorobenzenes; Dimethylamines; Fluorinated hydrocarbons; Glucosides; Ketones; Phenyl ethers; Piperidines; Pyrans; Pyrimidines; Small molecules
  • Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors; Sodium-glucose transporter 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Unspecified

Most Recent Events

  • 19 Feb 2026 Chemical structure information and Related CAS numbers added.
  • 09 Feb 2026 LG Chem plans a phase I pharmacokinetics trial (In volunteers) in Thailand (PO, Controlled-release) in July 2026 (NCT07396844)
  • 09 Jan 2026 LG Chem initiates a phase I trial in Unspecified (In volunteers) in South Korea (PO) (NCT07399470)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top